mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
2e-16 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
5e-12 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
6e-09 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
1e-08 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
4e-08 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
5e-07 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
1e-06 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.22 |
1e-06 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-06 |
mRNA |
LY317615 |
GDSC1000 |
pan-cancer |
AAC |
0.23 |
2e-06 |